Observational Study of Venus P-Valve
Condition(s) studied
Investigational drug(s) / intervention(s)
transcatheter pulmonary valve implantation (TPVI): A stent-mounted valve is introduced over a guidewire and positioned in the RVOT, followed by balloon inflation to deploy the valve.
Study summary
Real-world evidence, retrospective and prospective, non-randomized, multicenter observational study of VenusP-ValveTM System in treating moderate or greater pulmonary regurgitation with/without pulmonary stenosis in patients with native right ventricular outflow tract (RVOT).
Eligibility
Primary outcome measure(s)
- Non-hierarchical composite endpoint — at six months
* Freedom from VenusP-ValveTM (catheter or surgical) reintervention * Acceptable hemodynamic function, defined as: 1. Mild or less regurgitation measured by echocardiography; AND 2. Mean RVOT gradient as measured by echocardiography ≤35mmHg.
Trial sites (10)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU Bordeaux | Pessac | New Aquitaine | Not Yet Recruiting |
| Chu Nantes | Nantes | Pays de la Loire Region | Recruiting |
| Marie Lannelongue | Le Plessis-Robinson | Île-de-France Region | Recruiting |
| Hopital Necker-Enfants malades | Paris | Île-de-France Region | Recruiting |
| Heart CenterMunich | Munich | Bavaria | Not Yet Recruiting |
| Clinic of Congenital Heart Disease | Berlin | State of Berlin | Not Yet Recruiting |
| OPBG Rome | Rome | Lazio | Not Yet Recruiting |
| S. Donato Milan | Milan | Lombardy | Not Yet Recruiting |
| Leeds General Infirmary | Leeds | England | Not Yet Recruiting |
| Evelina Children's Hospital | London | England | Not Yet Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05835349 on ClinicalTrials.gov ↗ ← All trials in Italy